Rajendra Rampersaud, MD
Pulmonary Disease Physician in Yonkers, New York. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,271 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Rajendra Rampersaud, MD reported a CMS MIPS final score of 37/100 - below the 83.1 national average - and filed 372 Medicare Part D claims in 2023.
- 37/100
- MIPS score · -46 vs avg
- 372
- Part D claims, 2023
- 0%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Rajendra Rampersaud, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
37 4th percentile higher than 4% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Rajendra Rampersaud, MD sits
This provider among pulmonary disease physician peers
Across the 2,676 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Rajendra Rampersaud, MD writes more Part D claims than 26% of them and scores higher on MIPS quality than 6% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Rajendra Rampersaud, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Rajendra Rampersaud, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Rajendra Rampersaud, MD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New York
How Pulmonary Disease Physician compares to other specialties among New York providers
Pulmonary Disease Physician ranks #79 among New York's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the New York provider total, by primary NUCC taxonomy. The highlighted bar is Pulmonary Disease Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Rajendra Rampersaud, MD's 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 37/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pulmonary Disease Physician) - 37/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Pulmonary Disease Physician US NPIs
37/100 MIPS final score - 46.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Pulmonary Disease Physician. Quality dim: 41.2. Cost dim: 35.1.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Rajendra Rampersaud, MD appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding MD credentials at 970 NORTH BROADWAY SUITE 209, Yonkers, NY, 10701, with a listed phone of (914) 965-3366. NPI 1003906801 was issued on 10/13/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Rampersaud most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 372 prescription claims written by this provider, covering 84 Medicare beneficiaries and totaling roughly $220K in drug spend, split 77% brand-name and 0% generic by claim count. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 37/100 for the 2023 performance year (Quality 41.2, Cost 35.1), compared with the national average of 83.1.
Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1003906801 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 10/13/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Rajendra Rampersaud, MD's current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Hospital and facility affiliations
Facilities where Rajendra Rampersaud, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Rajendra Rampersaud, MD. Source: openpaymentsdata.cms.gov.
Total received
$1.0K
Largest payer
GlaxoSmithKline, LLC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Rajendra Rampersaud, MD. To verify Rajendra Rampersaud, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
77% brand-name claims vs 0% generic, on 372 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 584
- Total Day Supply
- 16,842
- Brand vs Generic
- 77% brand / 0% generic
- Brand Drug Cost
- $217K
- Antibiotic Claims
- 13
Patient Demographics
- Average Patient Age
- 74.9 years
- Avg HCC Risk Score
- 1.85
- Gender Split
- 63% female / 37% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Rajendra Rampersaud, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Trelegy Ellipta
Trelegy Ellipta
98 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
63 claims
- Anoro Ellipta 36
Anoro Ellipta
36 claims
- Breo Ellipta 32
Breo Ellipta
32 claims
- Symbicort 20
Symbicort
20 claims
- Azithromycin 12
Azithromycin
12 claims
- Belsomra 12
Belsomra
12 claims
- Fluticasone Propio… 11
Fluticasone Propionate
11 claims
| Drug | Claims |
|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 98 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 63 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 36 |
| Breo Ellipta Fluticasone/Vilanterol | 32 |
| Symbicort Budesonide/Formoterol Fumarate | 20 |
| Azithromycin | 12 |
| Belsomra Suvorexant | 12 |
| Fluticasone Propionate | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Rajendra Rampersaud, MD fits within the Pulmonary Disease Physician landscape nationally.
Rajendra Rampersaud, MD's 372 claims are below the specialty average of 1,457.
Nearby Pulmonary Disease Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Rampersaud.
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pulmonary Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New York
Frequently Asked Questions
What is Rajendra Rampersaud, MD's specialty? ▼
How much does Rajendra Rampersaud, MD prescribe under Medicare Part D? ▼
What is Rajendra Rampersaud, MD's Medicare quality score? ▼
Where is Rajendra Rampersaud, MD located? ▼
What is Rajendra Rampersaud, MD's NPI number? ▼
Does Rajendra Rampersaud, MD prescribe more brand-name or generic drugs? ▼
How many Pulmonary Disease Physician providers are there in the US? ▼
What drugs does Rajendra Rampersaud, MD prescribe most often? ▼
Does Rajendra Rampersaud, MD accept Medicare? ▼
How can I verify Rajendra Rampersaud, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology